What is he best known for?
The fields of study he is best known for:
- Gene
- Antibody
- Immune system
His main research concerns Antibody, Virology, Epitope, Neutralization and Glycan.
His Antibody research includes themes of Lineage, Immune system, Antigen, Vaccination and Viral protein.
His study in Virology focuses on Virus in particular.
Gwo-Yu Chuang combines subjects such as Peptide sequence, Conserved sequence and Neutralizing antibody with his study of Epitope.
His research integrates issues of Monoclonal antibody and Binding site in his study of Neutralization.
Gwo-Yu Chuang works mostly in the field of Glycan, limiting it down to topics relating to Glycosylation and, in certain cases, Glycoprotein, Antigen-Antibody Complex, Oligosaccharide and Humoral immunity, as a part of the same area of interest.
His most cited work include:
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 (694 citations)
- Structure and immune recognition of trimeric pre-fusion HIV-1 Env (544 citations)
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus (524 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Antibody, Virology, Neutralization, Epitope and Trimer.
His Antibody study incorporates themes from Lineage, Glycosylation and Glycan.
His specific area of interest is Virology, where Gwo-Yu Chuang studies Virus.
His work deals with themes such as Glycoprotein and Vaccination, which intersect with Virus.
His Neutralization study also includes fields such as
- Potency which intersects with area such as Immunology,
- Fusion peptide most often made with reference to Priming.
His research integrates issues of Neutralizing antibody, Viral entry, Peptide sequence, Protein structure and Viral protein in his study of Epitope.
He most often published in these fields:
- Antibody (57.39%)
- Virology (56.52%)
- Neutralization (36.52%)
What were the highlights of his more recent work (between 2019-2021)?
- Antibody (57.39%)
- Virology (56.52%)
- Neutralization (36.52%)
In recent papers he was focusing on the following fields of study:
Gwo-Yu Chuang mainly investigates Antibody, Virology, Neutralization, Epitope and Glycan.
His study in the field of Somatic hypermutation also crosses realms of Antibody Classes.
His Virology study focuses on Vaccination in particular.
His work in Neutralization is not limited to one particular discipline; it also encompasses Neutralizing antibody.
His study in Epitope is interdisciplinary in nature, drawing from both Biophysics and Monoclonal antibody.
Many of his studies on Glycan involve topics that are commonly interrelated, such as Glycosylation.
Between 2019 and 2021, his most popular works were:
- Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains. (59 citations)
- Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. (33 citations)
- A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike (32 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Antibody
- Immune system
His primary areas of study are Virology, Epitope, Antibody, Severe acute respiratory syndrome coronavirus 2 and Antibody Classes.
His Virology research is multidisciplinary, incorporating elements of Adjuvant, Immunogen and Peptide.
Gwo-Yu Chuang has researched Epitope in several fields, including Neutralization and Neutralizing antibody.
His Neutralization research includes themes of Endosome, Viral envelope, Viral replication and Binding site.
The various areas that Gwo-Yu Chuang examines in his Neutralizing antibody study include Globular protein, Biophysics and Binding domain.
Gwo-Yu Chuang performs multidisciplinary study on Antibody and Trimer in his works.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
